This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
LOS ANGELES (Reuters) - United Parcel Service Inc (UPS.N) on Tuesday said it is testing “smart lock” technology that allows its delivery drivers to open doors and drop multiple packages at secure locations inside apartment buildings around New York City.The test includes “hundreds of non-doorman” multi-family buildings in Manhattan and Brooklyn that have installed Latch’s “smart access system.” The project comes as UPS is working to make “last-mile” e-commerce deliveries to households more convenient and cost effective by reducing package theft and the need for drivers to make repeated delivery attempts.
United Parcel Service Inc on Tuesday said it is testing "smart lock" technology that allows its delivery drivers to open doors and drop multiple packages at secure locations inside apartment buildings around New York City.
UPS (NYSE:UPS) today said it has begun a pilot with Latch smart access devices to enable in-building deliveries to multi-unit homes in New York City, providing increased security and convenience for residents who are not at home to receive packages.
ATLANTA, July 16, 2018 (GLOBE NEWSWIRE) -- UPS (NYSE:UPS) will announce its 2018 second-quarter results on Wednesday, July 25, 2018, at approximately 7 a.m. Eastern Time.
Union Pacific Corporation (UNP - Free Report) is slated to release second-quarter 2018 results on Jul 19, before the market opens. Last reported quarter, the company delivered a positive earnings surprise of 1.8%. The company posted better-than-expected earnings and revenues in the quarter. Moreover, both metrics improved on a year-over-year basis. Higher freight revenues boosted results. The company also boasts an impressive earnings history, having outperformed the Zacks Consensus Estimate in three of the last four quarters with an average beat of 1.
UPS UNP NTRS GTT NTRSP CSX
SAN DIEGO, July 16, 2018 (GLOBE NEWSWIRE) -- The UPS Store, Inc. and Inc. Magazine have announced the three finalists for the Small Biz Salute Pitch Off, a national competition that will reward one small business owner with $25,000 and an editorial feature in Inc. Magazine to help grow their business.
Kansas City Southern (KSU - Free Report) is scheduled to report second-quarter 2018 results on Jul 20, before the market opens. Last reported quarter, the company delivered a negative earnings surprise of 3.7%, having missed on both earnings and revenues. However, both metrics improved on a year-over-year basis. Results were boosted by volume growth and a strong performance of the Chemical & Petroleum unit.
UPS UNP NTRS GTT NTRSP KSU.PR CSX KSU
United Parcel Service Inc. and negotiators for the Teamsters union have reached a tentative agreement on a new five-year contract for unionized workers at the UPS Freight trucking division, the company said Friday.
ATLANTA, July 13, 2018 (GLOBE NEWSWIRE) -- UPS today announced a tentative agreement for a new Master UPS Freight Agreement with the International Brotherhood of Teamsters. The five-year agreement, which is subject to ratification, covers about 11,000 Teamsters-represented UPS Freight employees.
United Continental Holdings, Inc. (UAL - Free Report) is scheduled to report second-quarter 2018 results on Jul 17, after the market closes. Last reported quarter, the company delivered a positive earnings surprise of 2%. Both earnings and revenues surpassed estimates and increased year over year. Strong demand for air travel boosted results. However, with rising oil prices having engulfed the entire airline industry, the prospects for United Continental seem dismal in the second quarter.
UPS UNP UAL
CSX Corporation (CSX - Free Report) is slated to report second-quarter 2018 earnings on Jul 17 after market close. Last reported quarter, the company delivered a positive earnings surprise of 18.2% with better-than-expected earnings and revenues. Moreover, both the measures improved on a year-over-year basis. A substantial decrease in operating expenses also aided results. With the Precision Scheduled Railroading well underway, things look up for the company in the second quarter as well.
UPS UNP CSX
Canadian Pacific Railway Limited (CP - Free Report) is scheduled to report second-quarter 2018 results on Jul 18 after market close. Last reported quarter, the company came up with a negative earnings surprise of 1.4% on lower-than-expected earnings and revenues. Results were hurt by rough weather conditions. However, the top and the bottom line improved from the year-ago figures. Things do not look up for the company this to-be-reported quarter too.
CP CP UPS UNP
On its march towards world domination, e-retail and cloud giant Amazon (NASDAQ:AMZN) is disrupting a whole bunch of industries and creating tough times for companies of all shapes and sizes.
AMZN AMC UPS SPOT AAPL WBA P NFLX NYTAB
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to UPS / United Parcel Service, Inc. on message board site Silicon Investor.
as of ET